GlassScriptPhysician profile
Cynthia Dilauro
NPI 1023100476
$4,992.15
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $1,151 · 2021: $1,526 · 2022: $1,658.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $992.76 | 2019-2022 | |
| Novo Nordisk INC | $574.37 | 2019-2022 | |
| Pfizer INC. | $569.69 | 2019-2022 | |
| Allergan, INC. | $450.03 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $347.15 | 2019-2022 | |
| Lilly USA, LLC | $226.16 | 2020-2022 | |
| Amgen INC. | $202.59 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.43 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $169.14 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $154.80 | 2020-2021 | |
| Glaxosmithkline, LLC. | $152.31 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.16 | 2019-2022 | |
| Astellas Pharma US INC | $109.49 | 2022 | |
| Endo Pharmaceuticals INC. | $97.56 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $72.27 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $65.39 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $64.20 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.59 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $54.27 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $38.66 | 2021 | |
| Nevro Corp. | $37.98 | 2021-2022 | |
| Eisai INC. | $28.42 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.79 | 2022 | |
| Biogen, INC. | $24.62 | 2020 | |
| Janssen Pharmaceuticals, INC | $23.61 | 2021 | |
| Sunovion Pharmaceuticals INC. | $23.43 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.47 | 2021 | |
| Amneal Pharmaceuticals LLC | $15.36 | 2022 | |
| Bausch Health US, LLC | $14.78 | 2022 | |
| Abbott Laboratories | $13.49 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $12.89 | 2020 | |
| Amarin Pharma, INC. | $12.83 | 2019 | |
| Inogen, INC. | $11.73 | 2022 | |
| Vivus LLC | $11.73 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Dilauro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.